The global Percutaneous Urinary Catheter market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

A urinary catheter is a medical device that assists urination. It is usually inserted into the bladder through the urethra to draw urine out. In the structure of the urinary catheter, there is a balloon at the head end to fix the urinary catheter so that it can stay in the bladder to prevent prolapse.

From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Percutaneous Urinary Catheter leading manufacturers including Coloplast, C. R. Bard, Hollister, Teleflex, B. Braun, Medtronic, Adapta medical, APEXMED, ASID BONZ, ConvaTec, etc., dominate supply; the top five capture approximately % of global revenue, with Coloplast leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Percutaneous Urinary Catheter market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Percutaneous Urinary Catheter Market Report

Report Metric	Details
Report Name	Percutaneous Urinary Catheter Market
Segment by Type	Silica Gel Emulsion Others
Segment by Application	Hospital Clinic Home Care Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Coloplast, C. R. Bard, Hollister, Teleflex, B. Braun, Medtronic, Adapta medical, APEXMED, ASID BONZ, ConvaTec, Cook Medical, Cure Medical, Dynarex, Hunter Urology, Medical Technologies of Georgia, Pennine Healthcare, Romsons, Sisco Latex
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Percutaneous Urinary Catheter study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Percutaneous Urinary Catheter Market report?

Ans: The main players in the Percutaneous Urinary Catheter Market are Coloplast, C. R. Bard, Hollister, Teleflex, B. Braun, Medtronic, Adapta medical, APEXMED, ASID BONZ, ConvaTec, Cook Medical, Cure Medical, Dynarex, Hunter Urology, Medical Technologies of Georgia, Pennine Healthcare, Romsons, Sisco Latex

What are the Application segmentation covered in the Percutaneous Urinary Catheter Market report?

Ans: The Applications covered in the Percutaneous Urinary Catheter Market report are Hospital, Clinic, Home Care, Others

What are the Type segmentation covered in the Percutaneous Urinary Catheter Market report?

Ans: The Types covered in the Percutaneous Urinary Catheter Market report are Silica Gel, Emulsion, Others

1 Study Coverage

1.1 Introduction to Percutaneous Urinary Catheter: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Percutaneous Urinary Catheter Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Silica Gel

1.2.3 Emulsion

1.2.4 Others

1.3 Market Segmentation by Application

1.3.1 Global Percutaneous Urinary Catheter Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Home Care

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Percutaneous Urinary Catheter Revenue Estimates and Forecasts 2020-2031

2.2 Global Percutaneous Urinary Catheter Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Percutaneous Urinary Catheter Sales Estimates and Forecasts 2020-2031

2.4 Global Percutaneous Urinary Catheter Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Percutaneous Urinary Catheter Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Percutaneous Urinary Catheter Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Silica Gel Market Size by Manufacturers

3.5.2 Emulsion Market Size by Manufacturers

3.5.3 Others Market Size by Manufacturers

3.6 Global Percutaneous Urinary Catheter Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Percutaneous Urinary Catheter Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Percutaneous Urinary Catheter Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Percutaneous Urinary Catheter Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Percutaneous Urinary Catheter Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Percutaneous Urinary Catheter Sales and Revenue by Type (2020-2031)

6.4 North America Percutaneous Urinary Catheter Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Percutaneous Urinary Catheter Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Percutaneous Urinary Catheter Sales and Revenue by Type (2020-2031)

7.4 Europe Percutaneous Urinary Catheter Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Percutaneous Urinary Catheter Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Percutaneous Urinary Catheter Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Percutaneous Urinary Catheter Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Percutaneous Urinary Catheter Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Percutaneous Urinary Catheter Sales and Revenue by Type (2020-2031)

9.4 Central and South America Percutaneous Urinary Catheter Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Percutaneous Urinary Catheter Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Percutaneous Urinary Catheter Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Percutaneous Urinary Catheter Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Percutaneous Urinary Catheter Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Coloplast

11.1.1 Coloplast Corporation Information

11.1.2 Coloplast Business Overview

11.1.3 Coloplast Percutaneous Urinary Catheter Product Models, Descriptions and Specifications

11.1.4 Coloplast Percutaneous Urinary Catheter Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Coloplast Percutaneous Urinary Catheter Sales by Product in 2024

11.1.6 Coloplast Percutaneous Urinary Catheter Sales by Application in 2024

11.1.7 Coloplast Percutaneous Urinary Catheter Sales by Geographic Area in 2024

11.1.8 Coloplast Percutaneous Urinary Catheter SWOT Analysis

11.1.9 Coloplast Recent Developments

11.2 C. R. Bard

11.2.1 C. R. Bard Corporation Information

11.2.2 C. R. Bard Business Overview

11.2.3 C. R. Bard Percutaneous Urinary Catheter Product Models, Descriptions and Specifications

11.2.4 C. R. Bard Percutaneous Urinary Catheter Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 C. R. Bard Percutaneous Urinary Catheter Sales by Product in 2024

11.2.6 C. R. Bard Percutaneous Urinary Catheter Sales by Application in 2024

11.2.7 C. R. Bard Percutaneous Urinary Catheter Sales by Geographic Area in 2024

11.2.8 C. R. Bard Percutaneous Urinary Catheter SWOT Analysis

11.2.9 C. R. Bard Recent Developments

11.3 Hollister

11.3.1 Hollister Corporation Information

11.3.2 Hollister Business Overview

11.3.3 Hollister Percutaneous Urinary Catheter Product Models, Descriptions and Specifications

11.3.4 Hollister Percutaneous Urinary Catheter Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Hollister Percutaneous Urinary Catheter Sales by Product in 2024

11.3.6 Hollister Percutaneous Urinary Catheter Sales by Application in 2024

11.3.7 Hollister Percutaneous Urinary Catheter Sales by Geographic Area in 2024

11.3.8 Hollister Percutaneous Urinary Catheter SWOT Analysis

11.3.9 Hollister Recent Developments

11.4 Teleflex

11.4.1 Teleflex Corporation Information

11.4.2 Teleflex Business Overview

11.4.3 Teleflex Percutaneous Urinary Catheter Product Models, Descriptions and Specifications

11.4.4 Teleflex Percutaneous Urinary Catheter Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Teleflex Percutaneous Urinary Catheter Sales by Product in 2024

11.4.6 Teleflex Percutaneous Urinary Catheter Sales by Application in 2024

11.4.7 Teleflex Percutaneous Urinary Catheter Sales by Geographic Area in 2024

11.4.8 Teleflex Percutaneous Urinary Catheter SWOT Analysis

11.4.9 Teleflex Recent Developments

11.5 B. Braun

11.5.1 B. Braun Corporation Information

11.5.2 B. Braun Business Overview

11.5.3 B. Braun Percutaneous Urinary Catheter Product Models, Descriptions and Specifications

11.5.4 B. Braun Percutaneous Urinary Catheter Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 B. Braun Percutaneous Urinary Catheter Sales by Product in 2024

11.5.6 B. Braun Percutaneous Urinary Catheter Sales by Application in 2024

11.5.7 B. Braun Percutaneous Urinary Catheter Sales by Geographic Area in 2024

11.5.8 B. Braun Percutaneous Urinary Catheter SWOT Analysis

11.5.9 B. Braun Recent Developments

11.6 Medtronic

11.6.1 Medtronic Corporation Information

11.6.2 Medtronic Business Overview

11.6.3 Medtronic Percutaneous Urinary Catheter Product Models, Descriptions and Specifications

11.6.4 Medtronic Percutaneous Urinary Catheter Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Medtronic Recent Developments

11.7 Adapta medical

11.7.1 Adapta medical Corporation Information

11.7.2 Adapta medical Business Overview

11.7.3 Adapta medical Percutaneous Urinary Catheter Product Models, Descriptions and Specifications

11.7.4 Adapta medical Percutaneous Urinary Catheter Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Adapta medical Recent Developments

11.8 APEXMED

11.8.1 APEXMED Corporation Information

11.8.2 APEXMED Business Overview

11.8.3 APEXMED Percutaneous Urinary Catheter Product Models, Descriptions and Specifications

11.8.4 APEXMED Percutaneous Urinary Catheter Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 APEXMED Recent Developments

11.9 ASID BONZ

11.9.1 ASID BONZ Corporation Information

11.9.2 ASID BONZ Business Overview

11.9.3 ASID BONZ Percutaneous Urinary Catheter Product Models, Descriptions and Specifications

11.9.4 ASID BONZ Percutaneous Urinary Catheter Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 ASID BONZ Recent Developments

11.10 ConvaTec

11.10.1 ConvaTec Corporation Information

11.10.2 ConvaTec Business Overview

11.10.3 ConvaTec Percutaneous Urinary Catheter Product Models, Descriptions and Specifications

11.10.4 ConvaTec Percutaneous Urinary Catheter Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 ConvaTec Recent Developments

11.11 Cook Medical

11.11.1 Cook Medical Corporation Information

11.11.2 Cook Medical Business Overview

11.11.3 Cook Medical Percutaneous Urinary Catheter Product Models, Descriptions and Specifications

11.11.4 Cook Medical Percutaneous Urinary Catheter Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 Cook Medical Recent Developments

11.12 Cure Medical

11.12.1 Cure Medical Corporation Information

11.12.2 Cure Medical Business Overview

11.12.3 Cure Medical Percutaneous Urinary Catheter Product Models, Descriptions and Specifications

11.12.4 Cure Medical Percutaneous Urinary Catheter Sales, Price, Revenue and Gross Margin (2020-2025)

11.12.5 Cure Medical Recent Developments

11.13 Dynarex

11.13.1 Dynarex Corporation Information

11.13.2 Dynarex Business Overview

11.13.3 Dynarex Percutaneous Urinary Catheter Product Models, Descriptions and Specifications

11.13.4 Dynarex Percutaneous Urinary Catheter Sales, Price, Revenue and Gross Margin (2020-2025)

11.13.5 Dynarex Recent Developments

11.14 Hunter Urology

11.14.1 Hunter Urology Corporation Information

11.14.2 Hunter Urology Business Overview

11.14.3 Hunter Urology Percutaneous Urinary Catheter Product Models, Descriptions and Specifications

11.14.4 Hunter Urology Percutaneous Urinary Catheter Sales, Price, Revenue and Gross Margin (2020-2025)

11.14.5 Hunter Urology Recent Developments

11.15 Medical Technologies of Georgia

11.15.1 Medical Technologies of Georgia Corporation Information

11.15.2 Medical Technologies of Georgia Business Overview

11.15.3 Medical Technologies of Georgia Percutaneous Urinary Catheter Product Models, Descriptions and Specifications

11.15.4 Medical Technologies of Georgia Percutaneous Urinary Catheter Sales, Price, Revenue and Gross Margin (2020-2025)

11.15.5 Medical Technologies of Georgia Recent Developments

11.16 Pennine Healthcare

11.16.1 Pennine Healthcare Corporation Information

11.16.2 Pennine Healthcare Business Overview

11.16.3 Pennine Healthcare Percutaneous Urinary Catheter Product Models, Descriptions and Specifications

11.16.4 Pennine Healthcare Percutaneous Urinary Catheter Sales, Price, Revenue and Gross Margin (2020-2025)

11.16.5 Pennine Healthcare Recent Developments

11.17 Romsons

11.17.1 Romsons Corporation Information

11.17.2 Romsons Business Overview

11.17.3 Romsons Percutaneous Urinary Catheter Product Models, Descriptions and Specifications

11.17.4 Romsons Percutaneous Urinary Catheter Sales, Price, Revenue and Gross Margin (2020-2025)

11.17.5 Romsons Recent Developments

11.18 Sisco Latex

11.18.1 Sisco Latex Corporation Information

11.18.2 Sisco Latex Business Overview

11.18.3 Sisco Latex Percutaneous Urinary Catheter Product Models, Descriptions and Specifications

11.18.4 Sisco Latex Percutaneous Urinary Catheter Sales, Price, Revenue and Gross Margin (2020-2025)

11.18.5 Sisco Latex Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Percutaneous Urinary Catheter Industry Chain

12.2 Percutaneous Urinary Catheter Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Percutaneous Urinary Catheter Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Percutaneous Urinary Catheter Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Percutaneous Urinary Catheter Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Percutaneous Urinary Catheter Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Medical Technologies of Georgia

Pennine Healthcare

Romsons

Sisco Latex

List of Tables

Table 1. Global Percutaneous Urinary Catheter Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Percutaneous Urinary Catheter Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Percutaneous Urinary Catheter Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Percutaneous Urinary Catheter Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Percutaneous Urinary Catheter Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Percutaneous Urinary Catheter Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)

Table 7. Global Percutaneous Urinary Catheter Sales by Region (2020-2025) & (Units)

Table 8. Global Percutaneous Urinary Catheter Sales by Region (2026-2031) & (Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Percutaneous Urinary Catheter Sales by Manufacturers (2020-2025) & (Units)

Table 11. Global Percutaneous Urinary Catheter Sales Share by Manufacturers (2020-2025)

Table 12. Global Percutaneous Urinary Catheter Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Percutaneous Urinary Catheter Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Percutaneous Urinary Catheter by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Percutaneous Urinary Catheter as of 2024)

Table 16. Global Percutaneous Urinary Catheter Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Percutaneous Urinary Catheter Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Percutaneous Urinary Catheter Manufacturing Base and Headquarters

Table 19. Global Percutaneous Urinary Catheter Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Percutaneous Urinary Catheter Sales by Type (2020-2025) & (Units)

Table 23. Global Percutaneous Urinary Catheter Sales by Type (2026-2031) & (Units)

Table 24. Global Percutaneous Urinary Catheter Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Percutaneous Urinary Catheter Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Percutaneous Urinary Catheter ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Percutaneous Urinary Catheter Sales by Application (2020-2025) & (Units)

Table 29. Global Percutaneous Urinary Catheter Sales by Application (2026-2031) & (Units)

Table 30. Percutaneous Urinary Catheter High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Percutaneous Urinary Catheter Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Percutaneous Urinary Catheter Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Percutaneous Urinary Catheter ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Percutaneous Urinary Catheter Growth Accelerators and Market Barriers

Table 37. North America Percutaneous Urinary Catheter Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Percutaneous Urinary Catheter Sales (Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Percutaneous Urinary Catheter Growth Accelerators and Market Barriers

Table 40. Europe Percutaneous Urinary Catheter Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Percutaneous Urinary Catheter Sales (Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Percutaneous Urinary Catheter Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Percutaneous Urinary Catheter Sales (Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Percutaneous Urinary Catheter Growth Accelerators and Market Barriers

Table 45. Southeast Asia Percutaneous Urinary Catheter Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Percutaneous Urinary Catheter Investment Opportunities and Key Challenges

Table 47. Central and South America Percutaneous Urinary Catheter Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Percutaneous Urinary Catheter Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Percutaneous Urinary Catheter Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Coloplast Corporation Information

Table 51. Coloplast Description and Major Businesses

Table 52. Coloplast Product Models, Descriptions and Specifications

Table 53. Coloplast Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Coloplast Sales Value Proportion by Product in 2024

Table 55. Coloplast Sales Value Proportion by Application in 2024

Table 56. Coloplast Sales Value Proportion by Geographic Area in 2024

Table 57. Coloplast Percutaneous Urinary Catheter SWOT Analysis

Table 58. Coloplast Recent Developments

Table 59. C. R. Bard Corporation Information

Table 60. C. R. Bard Description and Major Businesses

Table 61. C. R. Bard Product Models, Descriptions and Specifications

Table 62. C. R. Bard Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. C. R. Bard Sales Value Proportion by Product in 2024

Table 64. C. R. Bard Sales Value Proportion by Application in 2024

Table 65. C. R. Bard Sales Value Proportion by Geographic Area in 2024

Table 66. C. R. Bard Percutaneous Urinary Catheter SWOT Analysis

Table 67. C. R. Bard Recent Developments

Table 68. Hollister Corporation Information

Table 69. Hollister Description and Major Businesses

Table 70. Hollister Product Models, Descriptions and Specifications

Table 71. Hollister Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Hollister Sales Value Proportion by Product in 2024

Table 73. Hollister Sales Value Proportion by Application in 2024

Table 74. Hollister Sales Value Proportion by Geographic Area in 2024

Table 75. Hollister Percutaneous Urinary Catheter SWOT Analysis

Table 76. Hollister Recent Developments

Table 77. Teleflex Corporation Information

Table 78. Teleflex Description and Major Businesses

Table 79. Teleflex Product Models, Descriptions and Specifications

Table 80. Teleflex Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Teleflex Sales Value Proportion by Product in 2024

Table 82. Teleflex Sales Value Proportion by Application in 2024

Table 83. Teleflex Sales Value Proportion by Geographic Area in 2024

Table 84. Teleflex Percutaneous Urinary Catheter SWOT Analysis

Table 85. Teleflex Recent Developments

Table 86. B. Braun Corporation Information

Table 87. B. Braun Description and Major Businesses

Table 88. B. Braun Product Models, Descriptions and Specifications

Table 89. B. Braun Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. B. Braun Sales Value Proportion by Product in 2024

Table 91. B. Braun Sales Value Proportion by Application in 2024

Table 92. B. Braun Sales Value Proportion by Geographic Area in 2024

Table 93. B. Braun Percutaneous Urinary Catheter SWOT Analysis

Table 94. B. Braun Recent Developments

Table 95. Medtronic Corporation Information

Table 96. Medtronic Description and Major Businesses

Table 97. Medtronic Product Models, Descriptions and Specifications

Table 98. Medtronic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Medtronic Recent Developments

Table 100. Adapta medical Corporation Information

Table 101. Adapta medical Description and Major Businesses

Table 102. Adapta medical Product Models, Descriptions and Specifications

Table 103. Adapta medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Adapta medical Recent Developments

Table 105. APEXMED Corporation Information

Table 106. APEXMED Description and Major Businesses

Table 107. APEXMED Product Models, Descriptions and Specifications

Table 108. APEXMED Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. APEXMED Recent Developments

Table 110. ASID BONZ Corporation Information

Table 111. ASID BONZ Description and Major Businesses

Table 112. ASID BONZ Product Models, Descriptions and Specifications

Table 113. ASID BONZ Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. ASID BONZ Recent Developments

Table 115. ConvaTec Corporation Information

Table 116. ConvaTec Description and Major Businesses

Table 117. ConvaTec Product Models, Descriptions and Specifications

Table 118. ConvaTec Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. ConvaTec Recent Developments

Table 120. Cook Medical Corporation Information

Table 121. Cook Medical Description and Major Businesses

Table 122. Cook Medical Product Models, Descriptions and Specifications

Table 123. Cook Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. Cook Medical Recent Developments

Table 125. Cure Medical Corporation Information

Table 126. Cure Medical Description and Major Businesses

Table 127. Cure Medical Product Models, Descriptions and Specifications

Table 128. Cure Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 129. Cure Medical Recent Developments

Table 130. Dynarex Corporation Information

Table 131. Dynarex Description and Major Businesses

Table 132. Dynarex Product Models, Descriptions and Specifications

Table 133. Dynarex Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 134. Dynarex Recent Developments

Table 135. Hunter Urology Corporation Information

Table 136. Hunter Urology Description and Major Businesses

Table 137. Hunter Urology Product Models, Descriptions and Specifications

Table 138. Hunter Urology Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 139. Hunter Urology Recent Developments

Table 140. Medical Technologies of Georgia Corporation Information

Table 141. Medical Technologies of Georgia Description and Major Businesses

Table 142. Medical Technologies of Georgia Product Models, Descriptions and Specifications

Table 143. Medical Technologies of Georgia Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 144. Medical Technologies of Georgia Recent Developments

Table 145. Pennine Healthcare Corporation Information

Table 146. Pennine Healthcare Description and Major Businesses

Table 147. Pennine Healthcare Product Models, Descriptions and Specifications

Table 148. Pennine Healthcare Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 149. Pennine Healthcare Recent Developments

Table 150. Romsons Corporation Information

Table 151. Romsons Description and Major Businesses

Table 152. Romsons Product Models, Descriptions and Specifications

Table 153. Romsons Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 154. Romsons Recent Developments

Table 155. Sisco Latex Corporation Information

Table 156. Sisco Latex Description and Major Businesses

Table 157. Sisco Latex Product Models, Descriptions and Specifications

Table 158. Sisco Latex Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 159. Sisco Latex Recent Developments

Table 160. Key Raw Materials Distribution

Table 161. Raw Materials Key Suppliers

Table 162. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 163. Milestones in Production Technology Evolution

Table 164. Distributors List

Table 165. Market Trends and Market Evolution

Table 166. Market Drivers and Opportunities

Table 167. Market Challenges, Risks, and Restraints

Table 168. Research Programs/Design for This Report

Table 169. Key Data Information from Secondary Sources

Table 170. Key Data Information from Primary Sources

List of Figures

Figure 1. Percutaneous Urinary Catheter Product Picture

Figure 2. Global Percutaneous Urinary Catheter Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Silica Gel Product Picture

Figure 4. Emulsion Product Picture

Figure 5. Others Product Picture

Figure 6. Global Percutaneous Urinary Catheter Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Hospital

Figure 8. Clinic

Figure 9. Home Care

Figure 10. Others

Figure 11. Percutaneous Urinary Catheter Report Years Considered

Figure 12. Global Percutaneous Urinary Catheter Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Percutaneous Urinary Catheter Revenue (2020-2031) & (US$ Million)

Figure 14. Global Percutaneous Urinary Catheter Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 15. Global Percutaneous Urinary Catheter Revenue Market Share by Region (2020-2031)

Figure 16. Global Percutaneous Urinary Catheter Sales (2020-2031) & (Units)

Figure 17. Global Percutaneous Urinary Catheter Sales (CAGR) by Region (2020-2031) (Units)

Figure 18. Global Percutaneous Urinary Catheter Sales Market Share by Region (2020-2031)

Figure 19. Top 5 and Top 10 Manufacturers Percutaneous Urinary Catheter Sales Volume Market Share in 2024

Figure 20. Global Percutaneous Urinary Catheter Revenue Market Share Ranking (2024)

Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 22. Silica Gel Revenue Market Share by Manufacturer in 2024

Figure 23. Emulsion Revenue Market Share by Manufacturer in 2024

Figure 24. Others Revenue Market Share by Manufacturer in 2024

Figure 25. Global Percutaneous Urinary Catheter Sales Market Share by Type (2020-2031)

Figure 26. Global Percutaneous Urinary Catheter Revenue Market Share by Type (2020-2031)

Figure 27. Global Percutaneous Urinary Catheter Sales Market Share by Application (2020-2031)

Figure 28. Global Percutaneous Urinary Catheter Revenue Market Share by Application (2020-2031)

Figure 29. North America Percutaneous Urinary Catheter Sales YoY (2020-2031) & (Units)

Figure 30. North America Percutaneous Urinary Catheter Revenue YoY (2020-2031) & (US$ Million)

Figure 31. North America Top 5 Manufacturers Percutaneous Urinary Catheter Sales Revenue (US$ Million) in 2024

Figure 32. North America Percutaneous Urinary Catheter Sales Volume (Units) by Type (2020- 2031)

Figure 33. North America Percutaneous Urinary Catheter Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 34. North America Percutaneous Urinary Catheter Sales Volume (Units) by Application (2020-2031)

Figure 35. North America Percutaneous Urinary Catheter Sales Revenue (US$ Million) by Application (2020-2031)

Figure 36. US Percutaneous Urinary Catheter Revenue (2020-2031) & (US$ Million)

Figure 37. Canada Percutaneous Urinary Catheter Revenue (2020-2031) & (US$ Million)

Figure 38. Mexico Percutaneous Urinary Catheter Revenue (2020-2031) & (US$ Million)

Figure 39. Europe Percutaneous Urinary Catheter Sales YoY (2020-2031) & (Units)

Figure 40. Europe Percutaneous Urinary Catheter Revenue YoY (2020-2031) & (US$ Million)

Figure 41. Europe Top 5 Manufacturers Percutaneous Urinary Catheter Sales Revenue (US$ Million) in 2024

Figure 42. Europe Percutaneous Urinary Catheter Sales Volume (Units) by Type (2020-2031)

Figure 43. Europe Percutaneous Urinary Catheter Sales Revenue (US$ Million) by Type (2020-2031)

Figure 44. Europe Percutaneous Urinary Catheter Sales Volume (Units) by Application (2020-2031)

Figure 45. Europe Percutaneous Urinary Catheter Sales Revenue (US$ Million) by Application (2020-2031)

Figure 46. Germany Percutaneous Urinary Catheter Revenue (2020-2031) & (US$ Million)

Figure 47. France Percutaneous Urinary Catheter Revenue (2020-2031) & (US$ Million)

Figure 48. U.K. Percutaneous Urinary Catheter Revenue (2020-2031) & (US$ Million)

Figure 49. Italy Percutaneous Urinary Catheter Revenue (2020-2031) & (US$ Million)

Figure 50. Russia Percutaneous Urinary Catheter Revenue (2020-2031) & (US$ Million)

Figure 51. Asia-Pacific Percutaneous Urinary Catheter Sales YoY (2020-2031) & (Units)

Figure 52. Asia-Pacific Percutaneous Urinary Catheter Revenue YoY (2020-2031) & (US$ Million)

Figure 53. Asia-Pacific Top 8 Manufacturers Percutaneous Urinary Catheter Sales Revenue (US$ Million) in 2024

Figure 54. Asia-Pacific Percutaneous Urinary Catheter Sales Volume (Units) by Type (2020- 2031)

Figure 55. Asia-Pacific Percutaneous Urinary Catheter Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 56. Asia-Pacific Percutaneous Urinary Catheter Sales Volume (Units) by Application (2020-2031)

Figure 57. Asia-Pacific Percutaneous Urinary Catheter Sales Revenue (US$ Million) by Application (2020-2031)

Figure 58. Indonesia Percutaneous Urinary Catheter Revenue (2020-2031) & (US$ Million)

Figure 59. Japan Percutaneous Urinary Catheter Revenue (2020-2031) & (US$ Million)

Figure 60. South Korea Percutaneous Urinary Catheter Revenue (2020-2031) & (US$ Million)

Figure 61. China Taiwan Percutaneous Urinary Catheter Revenue (2020-2031) & (US$ Million)

Figure 62. India Percutaneous Urinary Catheter Revenue (2020-2031) & (US$ Million)

Figure 63. Central and South America Percutaneous Urinary Catheter Sales YoY (2020-2031) & (Units)

Figure 64. Central and South America Percutaneous Urinary Catheter Revenue YoY (2020-2031) & (US$ Million)

Figure 65. Central and South America Top 5 Manufacturers Percutaneous Urinary Catheter Sales Revenue (US$ Million) in 2024

Figure 66. Central and South America Percutaneous Urinary Catheter Sales Volume (Units) by Type (2021-2031)

Figure 67. Central and South America Percutaneous Urinary Catheter Sales Revenue (US$ Million) by Type (2020-2031)

Figure 68. Central and South America Percutaneous Urinary Catheter Sales Volume (Units) by Application (2020-2031)

Figure 69. Central and South America Percutaneous Urinary Catheter Sales Revenue (US$ Million) by Application (2020-2031)

Figure 70. Brazil Percutaneous Urinary Catheter Revenue (2020-2025) & (US$ Million)

Figure 71. Argentina Percutaneous Urinary Catheter Revenue (2020-2025) & (US$ Million)

Figure 72. Middle East, and Africa Percutaneous Urinary Catheter Sales YoY (2020-2031) & (Units)

Figure 73. Middle East and Africa Percutaneous Urinary Catheter Revenue YoY (2020-2031) & (US$ Million)

Figure 74. Middle East and Africa Top 5 Manufacturers Percutaneous Urinary Catheter Sales Revenue (US$ Million) in 2024

Figure 75. Middle East and Africa Percutaneous Urinary Catheter Sales Volume (Units) by Type (2021-2031)

Figure 76. South America Percutaneous Urinary Catheter Sales Revenue (US$ Million) by Type (2020-2031)

Figure 77. Middle East and Africa Percutaneous Urinary Catheter Sales Volume (Units) by Application (2020-2031)

Figure 78. Middle East and Africa Percutaneous Urinary Catheter Sales Revenue (US$ Million) by Application (2020-2031)

Figure 79. GCC Countries Percutaneous Urinary Catheter Revenue (2020-2025) & (US$ Million)

Figure 80. Turkey Percutaneous Urinary Catheter Revenue (2020-2025) & (US$ Million)

Figure 81. Egypt Percutaneous Urinary Catheter Revenue (2020-2025) & (US$ Million)

Figure 82. South Africa Percutaneous Urinary Catheter Revenue (2020-2025) & (US$ Million)

Figure 83. Percutaneous Urinary Catheter Industry Chain Mapping

Figure 84. Regional Percutaneous Urinary Catheter Manufacturing Base Distribution (%)

Figure 85. Global Percutaneous Urinary Catheter Production Market Share by Region (2020-2031)

Figure 86. Percutaneous Urinary Catheter Production Process

Figure 87. Regional Percutaneous Urinary Catheter Production Cost Structure

Figure 88. Channels of Distribution (Direct Vs Distribution)

Figure 89. Bottom-up and Top-down Approaches for This Report

Figure 90. Data Triangulation

Figure 91. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions